On this page
Ming Xian
Insider
First SEC filing: July 6, 2020 · Latest: July 6, 2020
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | MED | A | 11,680 | · | · | 43,823 Direct | +36.34% | Acquired | (price as of 2026-10-05) |
| June 25, 2025 | MED | A | 11,168 | · | · | 26,130 Direct | +74.64% | Acquired | (price as of 2026-10-05) |
| June 25, 2025 | MED | A | 6,013 | $13.39 | $80,514 | 32,143 Direct | +23.01% | Acquired | -12.8% (price as of 2026-10-05) |
| June 20, 2024 | MED | A | 10,149 | · | · | 14,962 Direct | +210.87% | Acquired | (price as of 2026-10-05) |
| Nov. 7, 2023 | MED | P | 48 | $68.89 | $3,307 | 4,813 Direct | +1.01% | Acquired | -83.0% (price as of 2026-10-05) |
| Aug. 8, 2023 | MED | P | 37 | $89.42 | $3,309 | 4,764 Direct | +0.78% | Acquired | -86.9% (price as of 2026-10-05) |
| June 15, 2023 | MED | A | 2,742 | · | · | 4,728 Direct | +138.07% | Acquired | (price as of 2026-10-05) |
| May 9, 2023 | MED | P | 12 | $87.50 | $1,050 | 1,986 Direct | +0.61% | Acquired | -86.7% (price as of 2026-10-05) |
| Feb. 7, 2023 | MED | A | 9 | $114.97 | $1,035 | 1,973 Direct | +0.46% | Acquired | -89.8% (price as of 2026-10-05) |
| Nov. 8, 2022 | MED | A | 10 | $106.93 | $1,069 | 1,964 Direct | +0.51% | Acquired | -89.1% (price as of 2026-10-05) |
| Aug. 8, 2022 | MED | A | 7 | $138.78 | $971 | 1,954 Direct | +0.36% | Acquired | -91.6% (price as of 2026-10-05) |
| June 16, 2022 | MED | A | 1,317 | · | · | 1,947 Direct | +209.05% | Acquired | (price as of 2026-10-05) |
| June 3, 2021 | MED | A | 630 | · | · | 2,751 Direct | +29.70% | Acquired | (price as of 2026-10-05) |
| July 2, 2020 | MED | A | 1,083 | · | · | 2,121 Direct | +104.34% | Acquired | (price as of 2026-10-05) |
| Feb. 22, 2019 | MED | A | 1,038 | · | · | 1,038 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 11,680 | Acquired |
| June 25, 2025 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 11,168 | Acquired |
| June 25, 2025 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 6,013 | Acquired |
| June 20, 2024 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 10,149 | Acquired |
| Nov. 7, 2023 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 48 | Acquired |
| Aug. 8, 2023 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 37 | Acquired |
| June 15, 2023 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 2,742 | Acquired |
| May 9, 2023 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 12 | Acquired |
| Feb. 7, 2023 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 9 | Acquired |
| Nov. 8, 2022 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 10 | Acquired |
| Aug. 8, 2022 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 7 | Acquired |
| June 16, 2022 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 1,317 | Acquired |
| June 3, 2021 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 630 | Acquired |
| July 2, 2020 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 1,083 | Acquired |
| Feb. 22, 2019 | MED | Restricted Stock Units (cash settled) | Common Stock | · | · | 1,038 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).